Lorin Hirsch in Lancaster, Pennsylvania

Medical School: Temple University School Of Medicine
Graduation Year: 1986
The Primary Medical Specialty for Lorin Hirsch is listed as: Family Practice
Approximate Years of Experience: 38
PAC (PECOS ID)#: 8426103300
NPI #: 1700805348
NPI Created On: 07/18/2006
NPI Last Updated Listed as: 01/09/2021
Primary Taxonomy Code: 207Q00000X
License Number:
MD039274E
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Capital Advantage Assurance Company
• Highmark Health Insurance Company
• Highmark Inc.
• UPMC Health Options, Inc.
• Geisinger Health Plan
• Geisinger Quality Options
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Aspiration and/or injection of large joint or joint capsule
2. Insertion of needle into vein for collection of blood sample
3. Automated urinalysis test
4. Pneumococcal vaccine for injection into muscle
5. Vaccine for influenza for injection into muscle
6. Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
7. Routine ekg using at least 12 leads including interpretation and report
8. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
9. Established patient office or other outpatient visit, typically 15 minutes
10. Established patient office or other outpatient, visit typically 25 minutes
11. Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge
12. Administration of influenza virus vaccine
13. Administration of pneumococcal vaccine
14. Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment
15. Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit
16. Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
17. Annual depression screening, 15 minutes
18. Injection, denosumab, 1 mg
19. Injection, triamcinolone acetonide, not otherwise specified, 10 mg